Asia 1Q Preview: Mixed China, Korea Outlook As Policies, Economics Bite
Executive Summary
As major companies start to release their quarterly results over the next few weeks, Scrip's sister publication PharmAsia News takes a market-by-market look at some of the key expectations, challenges and policy factors likely to have the biggest influence on Asia's major corporate players.
You may also be interested in...
Asia 1Q Preview: Japan Policy Worries, Indian Mixed Bag
As major companies start to release their quarterly results over the next few weeks, Scrip and sister publication PharmAsia News take a market-by-market look at some of the key expectations, challenges and policy factors likely to have the biggest influence on Asia's major corporate players.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.